Crepey Skin Treatments Market

How big is Crepey Skin Treatments Market in 2026?

USD 829.2 million in 2026 and USD 1,429.9 million by 2036 at a 5.6% CAGR.

Demand for crepey skin treatments is projected to expand at 5.6% CAGR between 2026 and 2036, increasing valuation from USD 829.2 million to USD 1,429.9 million. Regular neck and body application makes visible-texture care a repeat purchase after regimen adoption. UN DESA documented 1.22 billion people aged 60 years or older worldwide in February 2026. The mature-consumer pool widens age-focused body-care demand, though uptake still depends on proof and comfort.

The UAE is projected to outpace the USA by one percentage point through 2036 because premium discovery is concentrated in fewer retail hubs. FDA data through June 30, 2026 listed 1,298,361 active cosmetic product listings under MoCRA. Annual updates and ingredient records make broad USA portfolios more administrative. Faster UAE growth does not imply a larger current revenue pool.

Key Takeaways

• Mature-skin dryness and visible texture concerns support repeat demand for body-area products with credible smoothing or firming claims.
• Core - classic lines are projected to account for 33.0% of product type demand in 2026, owing to familiar routines that lower switching friction.
• Conventional formulations are estimated to hold 52.0% by nature in 2026, supported by wider ingredient and preservation choices for multi-benefit treatment formulas.
• Cream & balm is set to capture 30.0% by format in 2026, attributable to coverage and emollience that suit larger dry body areas.
• Claim substantiation and active-related irritation can reduce repeat use if visible-results language outruns tolerability or supporting evidence.
• Key players in the crepey skin treatments market include Shiseido, Kao Corporation, Unilever, Procter & Gamble, Amorepacific, L'Oreal, Coty, e.l.f. Beauty, Beiersdorf, and Estee Lauder Companies.

Analyst Perspective

"Crepey-skin portfolios earn repeat business through body-area claims backed by tolerability evidence. Stronger offers pair that proof with pack economics that make regular neck and body application affordable."

- Rahul Pandita, Principal Consultant, Future Market Insights

How is the crepey skin treatments market segmented?

The market is segmented by Product Type, Nature, Format, Price Positioning, and Sales Channel.

The crepey skin treatments market is segmented by product type, nature, format, price positioning and sales channel. Product type includes core - classic lines, targeted treatment lines, sensitive & gentle lines, premium & clinical lines and kits & sets. Nature covers conventional, vegan & cruelty-free, natural & organic, dermocosmetic - clinical and fragrance-free & sensitive. Format includes cream & balm, liquid & serum, stick & solid, spray & mist, sheet & patch and powder. Price positioning includes mass, masstige, premium and professional. Sales channels cover e-commerce & DTC, specialty beauty retail, pharmacies & drugstores, supermarkets & hypermarkets and salons & spas.

What makes Core - classic lines central to the Product Type category?

Familiar franchises reduce trial risk for shoppers using anti-aging creams for visible texture. Shiseido renewed ULTIMUNE in March 2025 within its established skin-aging care program. Long-running lines can absorb treatment science without requiring consumers to adopt a separate regimen.

• Core - classic lines are estimated to hold 33.0% of product type demand in 2026 owing to broad routine fit and familiar use with lower switching friction.
• Long-running franchises can extend validated actives into neck or body care after tolerability testing, giving retailers a clearer replenishment story and fewer consumer education steps than narrowly episodic correction products.

Why does Conventional lead the Nature category?

Conventional formulas give developers wider latitude in cosmetic chemicals selection for humectants and preservation. Beiersdorf disclosed in March 2026 that its 2025 program included fragrance-free Eucerin firming care for mature dry skin. Mainstream formulation platforms can address sensitivity without making a natural claim central.

• Conventional is forecast to represent 52.0% of nature demand in 2026 due to formulation flexibility and broad availability across mass and prestige price points.
• Specialist nature claims can strengthen differentiation, though tighter ingredient or sourcing constraints may narrow texture choices during stability and sensory work.

How does Cream & balm hold the leading Format position?

Cream and balm formats suit body firming creams because they cover dry areas without facial-dose economics. Kao introduced SENSAI TOTAL FORM EXPERT CREAM in July 2025 for September rollout in more than 40 countries. Neck-inclusive use and firmness positioning keep creams relevant to routines requiring spreadability and moisture.

• In 2026, cream & balm is expected to lead format with 30.0% share because spreadability and moisture retention support regular neck and body application.
• Serums signal concentrated actives, but creams give formulators more room to balance treatment ingredients with the cushioning feel needed by dry mature skin.

What supports Mass as the leading Price Positioning tier?

Body-area treatment consumes more product than facial-only routines, so price directly affects regimen continuity in anti-aging skincare. Procter & Gamble launched Olay Super Serum Body Wash in February 2025 with serum-inspired ingredients, extending treatment language into an accessible daily cleansing format.

• Mass is projected to hold 36.0% of price-positioning demand in 2026 owing to lower per-use cost across arms and neck plus chest and legs during sustained daily application.
• Premium tiers can justify higher prices with stronger testing or differentiated actives. Large pack consumption places a practical ceiling on routine spending over time.

What drives E-commerce & DTC to the leading Sales Channel position?

Digital channels give brands enough space to explain application zones beside broader skincare routines. Coty reported in February 2025 that e-commerce represented about 20% of company sales. Online sell-out grew by double digits in prestige and consumer beauty during the first half.

• E-commerce & DTC is likely to capture 31.0% of sales-channel demand in 2026 because education and replenishment can occur in one purchase path.
• Physical beauty and pharmacy channels retain an advantage for guided selection, whereas digital merchandising gives body-specific texture concerns more explanatory space than a crowded shelf or short pack panel.

What are the drivers, restraints and opportunities in the Crepey Skin Treatments Market?

Daily treatment of mature body skin supports demand, claim and irritation limits restrain stronger formulas, and body-specific testing can widen repeat purchasing.

• Driver: Mature-skin dryness and photoaging turn visible texture care into a routine purchase if moisturization and treatment benefits fit one daily step.
• Restraint: Ingredient limits and substantiation requirements raise reformulation or documentation costs for stronger wrinkle and firmness propositions.
• Opportunity: Brands can build body-specific regimens with credible testing, gentler active systems and pack sizes that support regular high-area application.

Routine cleansing can extend anti-wrinkle products care into the shower without requiring another leave-on step. Hindustan Unilever presented the Dove Serum Shower Collection in January 2025 with vitamin C plus AHA and salicylic acid. Treatment-led cleansing reduces regimen steps for consumers already managing dryness and visible body texture.

Retinol concentration limits directly affect body treatments positioned for visible skin aging. Commission Regulation (EU) 2024/996 set a 0.05% retinol-equivalent cap for body lotions and 0.3% for other leave-on or rinse-off cosmetic products, with new placing-on-market restrictions starting in November 2025 and full withdrawal of non-compliant products by May 2027. These limits make high-strength anti-aging body claims harder to scale in Europe because brands must reformulate, document exposure assumptions and keep visible-results language within tighter safety boundaries.

Body-specific firming care offers a clearer route than transferring facial claims unchanged. Shiseido announced a Clé de Peau Beauté Synactif body cream in May 2026 for a July launch with moisturization and firmness positioning. Companies can test large-area comfort and visible texture performance before extending claims into firming creams and serums.

Which country CAGRs are profiled in the Crepey Skin Treatments Market?

Country	CAGR
UAE	7.0%
South Korea	6.7%
Saudi Arabia	6.3%
USA	6.0%
France	5.7%
Germany	5.4%
UK	5.0%
Japan	4.7%

How do country-level CAGRs compare in the Crepey Skin Treatments Market?

UAE and South Korea form the upper tier with Saudi Arabia close behind. USA, France and Germany occupy the middle. UK and Japan advance more slowly through mature beauty channels.

• The UAE’s concentrated premium retail landscape accelerates consumer discovery and trial of advanced treatment products.
• South Korea’s fast-moving beauty market rapidly adopts and evaluates new treatment concepts and formats.
• Saudi Arabia rewards suppliers that enter the market with well-prepared import, registration, and launch strategies.
• The USA’s market scale increases the cost and complexity of building awareness for niche treatment categories.
• France’s pharmacy-focused distribution channels raise expectations for efficacy evidence and product credibility.
• Germany places greater scrutiny on treatment claims, making clear efficacy positioning essential for success.
• The UK’s diverse retail and online channels broaden access to treatment products across consumer segments.
• Japan’s consumers evaluate new treatment concepts through strong preferences for sensory performance and user experience.

Similar CAGRs therefore produce different launch economics and evidence burdens. The full report provides country-level CAGR analysis across North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Country-wise Analysis

• In the USA, large retailers and direct channels give body-texture treatments national reach, while crowded digital shelves make a narrow treatment purpose expensive to explain. USA Census Bureau data published in June 2025 put the population aged 65 or older at 61.2 million in 2024, establishing a large mature-skin user pool. Crepey skin treatment demand in the USA is forecast to rise at 6.0% CAGR over the forecast period, tied to scale in age-focused skin care and broad retail access. National distribution favors companies that can document visible-texture benefits and repeat-use economics before a dedicated regimen displaces routine healing skin care moisturizers.
• In Germany, pharmacies remain a trusted route for mature-skin formulas, especially among consumers who expect restrained efficacy language and repeat-use comfort in a crowded anti-aging category. Germany's crepey skin treatments outlook is anticipated to advance at 5.4% CAGR over the assessment period, owing to an older consumer base and established pharmacy demand. Destatis stated in June 2026 that people aged 60 or older represented 31% of Germany's population after increasing during 2025. Strong local brands make vague anti-aging claims easy to challenge, so entrants need a defined visible-texture job plus testing and clear claim boundaries before distribution broadens beyond core pharmacy channels.
• Dermocosmetic treatment claims gain authority in French pharmacies, although dense premium shelves leave little room for vague anti-aging positioning inside a mature prestige beauty market. Insee's January 2026 demographic report put people aged 65 or older at 22% of France's population at year start, confirming a sizeable mature consumer base. France is projected to grow at 5.7% CAGR through 2036, aided by established interest in efficacy-led age care and specialist recommendation. Entry depends on a body-area treatment job that pharmacists can explain at specialist counters because evidence quality carries more commercial weight than expanding sensitive skin solutions assortments in practice.
• Great Britain offers broad pharmacy and online access at national scale, but cosmetics follow a notification route separate from the EU system. GOV.UK guidance published in July 2025 requires a named Responsible Person and OPSS notification before a cosmetic product reaches consumers in Great Britain. Adoption of crepey skin treatments in the UK is estimated to expand at 5.0% CAGR through 2036, given mature skin-care use and broad channel coverage. Companies that settle notification ownership before inventory allocation can protect launch timing, whereas late label changes add cost to a shared European assortment and disrupt retailer delivery plans.
• Imported premium skin care gains wider reach in Saudi Arabia through modern beauty chains and digital channels at national scale, subject to a formal national notification route. SFDA's cosmetic notification page was updated in March 2025 and gives importers a defined documentation path for products entering the Saudi system. The Saudi Arabia crepey skin treatments sector is projected to record 6.3% CAGR during the assessment period, reinforced by wider access to premium treatment formats. Arabic-ready communication and complete product files are commercially important because clearance delays can erase seasonal retail windows before imported inventory reaches stores and promotional calendars begin.
• In Dubai, premium beauty stores and high e-commerce use create a concentrated route to first-time users of targeted body treatments. Crepey skin treatment demand in the UAE is predicted to advance at 7.0% CAGR through 2036, attributable to concentrated premium retail and digital product discovery. Dubai Municipality described Montaji in May 2025 as its smart platform for registering consumer products before local marketing for local sale. Registration timing can decide assortment speed, so companies that prepare files before campaign booking can align online launches with pharmacy availability and avoid premature media commitments during local retail rollout and pharmacy onboarding.
• Long experience with age-care routines shapes Japanese consumer expectations, with particular attention to comfortable texture on the neck and body in a mature market. Statistics Bureau data released in April 2025 put people aged 65 or older at 29.3% of the population, giving mature-skin care a large addressable base. Japan is estimated to post 4.7% CAGR over the forecast period, shaped by mature-skin needs inside a highly developed beauty category. Stronger wrinkle positioning can enter the quasi-drug route, so companies linking hyaluronic acid care with body treatment must plan local claims before launch and prove sensory fit beside efficacy.
• Performance-led skin care benefits from a familiar regulatory route in South Korea, where wrinkle-improvement claims can enter the functional-cosmetic system. MFDS amended its functional-cosmetics review rules in December 2025 and expanded selected submission exemptions for solid dosage forms used in qualifying wrinkle claims. Crepey skin treatment sales in South Korea are forecast to expand at 6.7% CAGR by 2036, propelled by fast product renewal and high treatment literacy. Companies linking K-beauty products with body care still need claim classification settled before export preparation, since rapid launch cycles quickly punish late evidence changes during retailer onboarding in practice.

Who are the notable companies in the Crepey Skin Treatments Market?

Shiseido, Kao Corporation, Unilever, Procter & Gamble, Amorepacific, L'Oreal, Coty, e.l.f. Beauty, Beiersdorf, and Estee Lauder Companies are notable companies serving this market.

Competition spans global beauty groups and specialist skin-care brands, and larger treatment areas raise entry barriers through proof quality and sensory performance.

• Shiseido and Kao Corporation maintain broad skin-science portfolios. Amorepacific and L'Oreal do as well. Beiersdorf and Estee Lauder Companies also support aging or sensitive-skin programs.
• Unilever and Procter & Gamble use mass body-care franchises to place treatment concepts inside familiar daily routines at accessible price points.
• Coty and e.l.f. Beauty use selective skin-care portfolios and digital reach, with acquisitions extending both companies deeper into treatment-led beauty.

Competitive Benchmarking: Crepey Skin Treatments Market

Company	Skin-Care Platform Breadth	Aging / Sensitive Treatment Depth	Omnichannel Skin-Care Reach	Geographic Reach
Shiseido	High	High	High	Global, strongest in Asia and prestige beauty
Kao Corporation	High	High	Medium	Japan, East Asia, Europe and selected Americas
Unilever	Medium	Medium	High	Global mass retail and e-commerce
Procter & Gamble	Medium	Medium	High	Global mass retail and e-commerce
Amorepacific	High	Medium	Medium	East Asia, North America and selected Europe
L'Oreal	High	High	High	Global mass, prestige, professional and dermatological beauty
Coty	Low	Low	Medium	Europe, North America, China and travel retail
e.l.f. Beauty	Medium	Low	High	North America, UK and expanding Europe
Beiersdorf	High	High	High	Global, including NIVEA and Eucerin
Estee Lauder Companies	High	High	High	Global prestige, specialty, travel retail and e-commerce

Scoring basis: High platform breadth requires three skin-care franchises, Medium requires two and Low one. High treatment depth requires aging plus sensitivity or barrier care, Medium one area and Low narrow evidence. High reach requires digital and physical routes in several regions, Medium fewer routes and Low one.

Key Developments in the Crepey Skin Treatments Market

• In December 2025, Amorepacific's IOPE launched Super Vital Neck & Decollete Cream for horizontal and vertical neck wrinkles plus firmness in the neck and clavicle area.
• In June 2025, L'Oreal signed an agreement to acquire a majority stake in Medik8 and add a science-led premium skin-care brand known for active-focused routines.
• In February 2025, Estee Lauder Companies partnered with Serpin Pharma to study anti-inflammatory technology for cosmetic approaches addressing skin aging plus irritation and sensitivity.

Key Players in the Crepey Skin Treatments Market

Global Skin-Science and Prestige Platforms

• Shiseido
• Kao Corporation
• Amorepacific
• L'Oreal
• Beiersdorf
• Estee Lauder Companies

Mass Skin and Body-Care Platforms

• Unilever
• Procter & Gamble

Selective and Digital Beauty Platforms

• Coty
• e.l.f. Beauty

Crepey Skin Treatments Market - Report Scope

Coverage field	Report scope
Market breakdown	By product type, nature, format, price positioning, sales channel and region.
Quantitative Units	USD million.
Market Definition	Topical cosmetic treatments positioned for visible crepey texture, dryness, fine wrinkling or firmness concerns on the face, neck or body.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	UAE, South Korea, Saudi Arabia, USA, France, Germany, UK, Japan, and 20+ countries included in the full report.
Key Companies Profiled	Shiseido, Kao Corporation, Unilever, Procter & Gamble, Amorepacific, L'Oreal, Coty, e.l.f. Beauty, Beiersdorf, Estee Lauder Companies.
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Crepey Skin Treatments Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Crepey Skin Treatments Market by Segments

Crepey Skin Treatments Market segmented by Product Type:

• Core - classic lines
• Targeted treatment lines
• Sensitive & gentle lines
• Premium & clinical lines
• Kits & sets

Crepey Skin Treatments Market segmented by Nature:

• Conventional
• Vegan & cruelty-free
• Natural & organic
• Dermocosmetic - clinical
• Fragrance-free & sensitive

Crepey Skin Treatments Market segmented by Format:

• Cream & balm
• Liquid & serum
• Stick & solid
• Spray & mist
• Sheet & patch
• Powder

Crepey Skin Treatments Market segmented by Price Positioning:

• Mass
• Masstige
• Premium
• Professional

Crepey Skin Treatments Market segmented by Sales Channel:

• E-commerce & DTC
• Specialty beauty retail
• Pharmacies & drugstores
• Supermarkets & hypermarkets
• Salons & spas

Crepey Skin Treatments Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
  • Rest of Western Europe
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel
  • Rest of Middle East and Africa

Research Sources and Bibliography

• United Nations Department of Economic and Social Affairs. (2026, February 27). UN DESA Policy Brief No. 186: Gender Matters in an Ageing World: The Case for Gender-responsive Policies.
• USA Food and Drug Administration. (2026, February 11). Registration & Listing of Cosmetic Product Facilities and Products.
• Shiseido Company, Limited. (2025, January 22). New ULTIMUNE to Debut Globally Starting March 2025.
• Beiersdorf AG. (2026, March 3). Research and Development - Beiersdorf Annual Report 2025.
• Kao Corporation. (2025, July 3). Kao Introduces SENSAI TOTAL FORM EXPERT CREAM.
• Procter & Gamble. (2025, February 22). OLAY Elevates Your Shower with New Super Serum Body Wash.
• Coty Inc. (2025, February 10). Coty Reports Solid 1H25 Financial Performance, With Strong Margin Expansion and Cash Generation in an Uncertain Market Environment.
• Hindustan Unilever Limited. (2025, January 22). DQ'24 Results.
• European Chemicals Agency. (2026, January 13). Cosmetic Products Regulation, Annex III - Restricted Substances: Vitamin A.
• European Commission. (2024, April 3). Commission Regulation (EU) 2024/996 amending Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR substances.
• Shiseido Company, Limited. (2026, May 20).
• USA Census Bureau. (2025, June 26). Older Adults Outnumber Children in 11 States and Nearly Half of USA Counties.
• German Federal Statistical Office (Destatis). (2026, June 16). Bevölkerung Deutschlands sinkt im Jahr 2025 um 0,1 %.
• Insee. (2026, January 13). Demographic report 2025: In 2025, natural balance was negative for the first time since the end of the Second World War.
• GOV.UK. (2025, July 10). Consumer products: cosmetics.
• Saudi Food and Drug Authority. (2025, March 11). Guidance and Requirements of Cosmetic product Notification.
• Dubai Municipality. (2025, May 9). 11 local and global award wins for innovation and excellence.
• Statistics Bureau of Japan. (2025, April 14). Current Population Estimates as of October 1, 2024.
• Ministry of Food and Drug Safety, Republic of Korea. (2025, December 16).
• Shiseido Company, Limited. (2026, May 12). Shiseido Integrated Report 2025.
• Kao Corporation. (2026, June 30). Kao Integrated Report 2026.
• Unilever PLC. (2026, March 5). Unilever Annual Report and Accounts 2025.
• Procter & Gamble. (2026). P&G's Focused Portfolio | P&G 2026 Annual Report.
• Amorepacific Group. (2026, February 6). Amorepacific Group 2025 Earnings Summary.
• L'Oreal Groupe. (2026). L'Oréal Annual Report 2025.
• Coty Inc. (2025, August 21). Coty Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2025.
• e.l.f. Beauty, Inc. (2026). Latest Annual Report / Form 10-K.
• Beiersdorf AG. (2026, March 3). Beiersdorf Annual Report 2025.
• The Estée Lauder Companies Inc. (2025, August 20). Fiscal 2025 Annual Report.
• Amorepacific. (2025, December 3). IOPE launches 'Super Vital Neck & Decollete Cream'.
• L'Oreal Groupe. (2025, June 9). L'Oreal Groupe to acquire majority stake in Medik8.
• The Estée Lauder Companies Inc. (2025, February 26). The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity.
• e.l.f. Beauty, Inc. (2025, May 28). e.l.f. Beauty Announces Definitive Agreement to Acquire rhode in $1 Billion Deal.
• Hindustan Unilever Limited. (2025). Integrated Annual Report 2024-25.
• Beiersdorf AG. (2025, August 13). Beiersdorf brings epigenetic innovation to the mass market.
• Shiseido Company, Limited. (2025, January 15). Co-creating Future Beauty by Connecting Researchers and Consumers at Shiseido Beauty Park Opening on January 22.
• L'Oreal Groupe. (2026, August 17). L'Oreal Groupe and NUS Medicine launch multi-year research partnership to advance longevity science.
• Shiseido Company, Limited. (2025, August 4). ELIXIR launches renewed retinol wrinkle cream on September 21, 2025.
• Kao Corporation. (2026, August 25). Kao Steps Up EMEA Skincare Growth with Curél Launch in the Nordics.
• Unilever PLC. (2026, August 19). Unilever and Galaxy Surfactants deepen partnership to accelerate innovation and growth.
• Procter & Gamble. (2026, August 27). Olay Launches 'Barrier Bootcamp' With New Repair Serum Body Wash Collection - Your Shower-Powered Workout for Skin Barrier Repair.
• Amorepacific. (2025, August 29). AP Beauty launches 'M.D. Serum' and three additional products.
• L'Oreal Groupe. (2025, March 21). L’Oréal announces strategic research partnership with Tru Diagnostic to advance beauty and longevity science, through unlocking discoveries in epigenomics.
• Coty Inc. (2025, March 21). Coty Divests Stake in SKKN by Kim.
• e.l.f. Beauty, Inc. (2026, August 31). rhode Announces Official Launch Date for Its Retail Expansion in Europe with Sephora.
• Beiersdorf AG. (2025, December 11). Beiersdorf launches Eucerin in Japan.
• The Estée Lauder Companies Inc. (2025, May 2). Estée Lauder Opens Skin Longevity Institute at Hacienda AltaGracia, Auberge Resorts Collection.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations

This Report Answers

• How large is the crepey skin treatments market through 2036?
• What turns visible crepey texture into repeat treatment demand?
• Which product type holds 33.0% share in 2026?
• Why do conventional formulas hold 52.0% by nature?
• Why do cream & balm formats lead larger-area treatment?
• Why does e-commerce & DTC lead sales channels?
• Which companies compete in crepey skin treatments?
• Which claim and ingredient rules slow wider adoption?